Cargando…

Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer?

Detalles Bibliográficos
Autor principal: Salimi, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pasteur Institute 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786661/
https://www.ncbi.nlm.nih.gov/pubmed/29101913
_version_ 1783295810985787392
author Salimi, Mona
author_facet Salimi, Mona
author_sort Salimi, Mona
collection PubMed
description
format Online
Article
Text
id pubmed-5786661
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Pasteur Institute
record_format MEDLINE/PubMed
spelling pubmed-57866612018-03-01 Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer? Salimi, Mona Iran Biomed J Study Break Pasteur Institute 2018-03 /pmc/articles/PMC5786661/ /pubmed/29101913 Text en Copyright: © Iranian Biomedical Journal http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Study Break
Salimi, Mona
Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer?
title Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer?
title_full Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer?
title_fullStr Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer?
title_full_unstemmed Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer?
title_short Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer?
title_sort future of triple negative breast cancer: can immunotherapy treat this deadly subtype of breast cancer?
topic Study Break
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5786661/
https://www.ncbi.nlm.nih.gov/pubmed/29101913
work_keys_str_mv AT salimimona futureoftriplenegativebreastcancercanimmunotherapytreatthisdeadlysubtypeofbreastcancer